The $5.1M of total grant support we've given to funding research is made possible by the generosity of our sponsors and donors. Real people making an impact on saving children's eyesight.
Grant History
Grant Amount
$2.1M
2025
Latest Posts
Have questions about A Race Against Blindness or our fundraiser sweepstakes? This hub page gathers all five articles from our Trust, Transparency, and Our Mission series — covering our story, our legal compliance, our real winners, and how you can verify us.
Blog Series Hub: Trust, Transparency, and Our Mission: The Truth About A Race Against Blindness
Article 1-5 linked here.
A groundbreaking Phase 2 trial has shown the first-ever vision improvements in people with Stargardt disease — a condition with no approved treatment. Nanoscope Therapeutics’ gene-agnostic MCO-010 therapy produced meaningful gains in vision without serious side effects, paving the way for a pivotal Phase 3 trial starting in 2025.
Blog Series: Trust, Transparency, and Our Mission: The Truth About A Race Against Blindness
Article 5: Our Commitment to Transparency & How You Can Verify Us
Blog Series: Trust, Transparency, and Our Mission: The Truth About A Race Against Blindness
Article 4: Why We Use Fundraiser Sweepstakes to Advance Our Mission
Blog Series: Trust, Transparency, and Our Mission: The Truth About A Race Against Blindness
Article 3: Winners & Where to Find Them